Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

editas medicine

POPULAR ARTICLES

Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101

Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update

Genetics Investing

Thom Calandra: Investing in Gene-editing Stocks

LATEST ARTICLES

Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference

Editas Medicine Extends CRISPR Genome Editing Licensing

Biotech Investing

CRISPR Therapeutics Now Trading on the NASDAQ

What Is CRISPR and Why Should Investors Care?

What Is CRISPR and Why Should Investors Care?

Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital

Biotech Investing

After Hot IPO Editas Medicine Bogged Down by CRISPR/Cas9 Legal Issues

Biotech Investing

Two Gene-focused Biotech Companies File for IPOs

Latest News

Syntheia Provides Telemarketer Services for Political Campaign in British Columbia

Forte Minerals Provides Update on Planned Drill Program at Pucarini High-Sulfidation Gold Project

Bold Ventures Announces Non-Brokered Private Placement and First Tranche Closing

Major Finland Gold Transaction

Halcones Precious Metals Closes Final Tranche of Life Offering and Announces Non-Brokered Offering